BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guillevin L, Lhote F, Cohen P, Jarrousse B, Lortholary O, Généreau T, Léon A, Bussel A. Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis. A prospective, randomized trial in sixty-two patients. Arthritis Rheum. 1995;38:1638-1645. [PMID: 7488285 DOI: 10.1002/art.1780381116] [Cited by in Crossref: 155] [Cited by in F6Publishing: 112] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Lau CF, Hui PK, Chan WM, Fung TT, Tung YM, Loo CK, Yip WC, Lam KM. Hepatitis B associated fulminant polyarteritis nodosa: successful treatment with pulse cyclophosphamide, prednisolone and lamivudine following emergency surgery: . European Journal of Gastroenterology & Hepatology 2002;14:563-6. [DOI: 10.1097/00042737-200205000-00016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
2 Hampson LV, Whitehead J, Eleftheriou D, Tudur-Smith C, Jones R, Jayne D, Hickey H, Beresford MW, Bracaglia C, Caldas A, Cimaz R, Dehoorne J, Dolezalova P, Friswell M, Jelusic M, Marks SD, Martin N, McMahon AM, Peitz J, van Royen-Kerkhof A, Soylemezoglu O, Brogan PA. Elicitation of expert prior opinion: application to the MYPAN trial in childhood polyarteritis nodosa. PLoS One 2015;10:e0120981. [PMID: 25822991 DOI: 10.1371/journal.pone.0120981] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
3 Brogan PA, Arch B, Hickey H, Anton J, Iglesias E, Baildam E, Mahmood K, Cleary G, Moraitis E, Papadopoulou C, Beresford MW, Riley P, Demir S, Ozen S, Culeddu G, Hughes DA, Dolezalova P, Hampson LV, Whitehead J, Jayne D, Ruperto N, Tudur-Smith C, Eleftheriou D. Mycophenolate Mofetil Versus Cyclophosphamide for Remission Induction in Childhood Polyarteritis Nodosa: An Open-Label, Randomized, Bayesian Noninferiority Trial. Arthritis Rheumatol 2021;73:1673-82. [PMID: 33760371 DOI: 10.1002/art.41730] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wright E, Dillon MJ, Tullus K. Childhood vasculitis and plasma exchange. Eur J Pediatr 2006;166:145-51. [DOI: 10.1007/s00431-006-0212-2] [Cited by in Crossref: 43] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
5 Gayraud M, Guillevin L, Le Toumelin P, Cohen P, Lhote F, Casassus P, Jarrousse B; the French Vasculitis Study Group. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: Analysis of four prospective trials including 278 patients. Arthritis & Rheumatism 2001;44:666-75. [DOI: 10.1002/1529-0131(200103)44:3<666::aid-anr116>3.0.co;2-a] [Cited by in Crossref: 347] [Cited by in F6Publishing: 80] [Article Influence: 17.4] [Reference Citation Analysis]
6 Abril A, Calamia KT, Cohen MD. The Churg Strauss syndrome (allergic granulomatous angiitis): review and update. Semin Arthritis Rheum 2003;33:106-14. [PMID: 14625818 DOI: 10.1016/s0049-0172(03)00083-0] [Cited by in Crossref: 98] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
7 Hiraike Y, Kodaira M, Sano M, Terazawa Y, Yamagata S, Terada S, Ohura M, Kuriki K. Polyarteritis nodosa diagnosed by surgically resected jejunal necrosis following acute abdomen. World J Gastroenterol 2013; 19(18): 2830-2834 [PMID: 23687422 DOI: 10.3748/wjg.v19.i18.2830] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
8 Yamada Y, Harada M, Hara Y, Iwabuchi R, Hashimoto K, Yamamoto S, Kamijo Y. Efficacy of plasma exchange for antineutrophil cytoplasmic antibody-associated systemic vasculitis: a systematic review and meta-analysis. Arthritis Res Ther 2021;23:28. [PMID: 33446268 DOI: 10.1186/s13075-021-02415-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Raffray L, Guillevin L. Updates for the treatment of EGPA. Presse Med 2020;49:104036. [PMID: 32652104 DOI: 10.1016/j.lpm.2020.104036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Eleftheriou D, Brogan PA. Therapeutic advances in the treatment of vasculitis. Pediatr Rheumatol Online J 2016;14:26. [PMID: 27112923 DOI: 10.1186/s12969-016-0082-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
11 Chung SA, Gorelik M, Langford CA, Maz M, Abril A, Guyatt G, Archer AM, Conn DL, Full KA, Grayson PC, Ibarra MF, Imundo LF, Kim S, Merkel PA, Rhee RL, Seo P, Stone JH, Sule S, Sundel RP, Vitobaldi OI, Warner A, Byram K, Dua AB, Husainat N, James KE, Kalot M, Lin YC, Springer JM, Turgunbaev M, Villa-Forte A, Turner AS, Mustafa RA. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Polyarteritis Nodosa. Arthritis Care Res (Hoboken) 2021;73:1061-70. [PMID: 34235889 DOI: 10.1002/acr.24633] [Reference Citation Analysis]
12 Jayne D. Evidence-based treatment of systemic vasculitis. Rheumatology (Oxford) 2000;39:585-95. [PMID: 10888702 DOI: 10.1093/rheumatology/39.6.585] [Cited by in Crossref: 64] [Cited by in F6Publishing: 36] [Article Influence: 3.0] [Reference Citation Analysis]
13 Kato T, Fujii K, Wakabayashi T, Tanaka A, Hidaka Y. A case of cutaneous polyarteritis nodosa manifested by spiking high fever, arthralgia and macular eruption like adult-onset Still's disease. Clin Rheumatol 2006;25:419-21. [DOI: 10.1007/s10067-005-0022-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
14 Anaev EK, Baranova IA, Belevsky AS. Pulmonary vasculitis: diagnosis and treatment. Ter Arkh 2018;90:99-106. [PMID: 30701864 DOI: 10.26442/terarkh201890399-106] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Guillevin L. Treatments for systemic vasculitides. Eur J Intern Med 2001;12:412-9. [PMID: 11557326 DOI: 10.1016/s0953-6205(01)00160-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Oh MJ, Lee JY, Kwon NH, Choi DC. Churg-Strauss syndrome: the clinical features and long-term follow-up of 17 patients. J Korean Med Sci 2006;21:265-71. [PMID: 16614512 DOI: 10.3346/jkms.2006.21.2.265] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
17 Ramakrishna G, Midthun DE. Churg-Strauss syndrome. Ann Allergy Asthma Immunol 2001;86:603-13; quiz 13. [PMID: 11428732 DOI: 10.1016/S1081-1206(10)62286-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
18 Kuru T, Lynch JP. NONRESOLVING OR SLOWLY RESOLVING PNEUMONIA. Clinics in Chest Medicine 1999;20:623-51. [DOI: 10.1016/s0272-5231(05)70241-0] [Cited by in Crossref: 51] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
19 Berti A, Specks U, Keogh KA, Cornec D. Current and Future Treatment Options for Eosinophilic Granulomatosis With Polyangiitis. Curr Treat Options in Rheum 2017;3:193-206. [DOI: 10.1007/s40674-017-0073-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
20 Conron M, Beynon HL. Churg-Strauss syndrome. Thorax 2000;55:870-7. [PMID: 10992542 DOI: 10.1136/thorax.55.10.870] [Cited by in Crossref: 66] [Cited by in F6Publishing: 49] [Article Influence: 3.1] [Reference Citation Analysis]
21 Sullivan EJ, Hoffman GS. Pulmonary vasculitis. Clin Chest Med 1998;19:759-76, ix. [PMID: 9917965 DOI: 10.1016/s0272-5231(05)70115-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
22 Guillevin L, Cohen P, Mahr A, Arène JP, Mouthon L, Puéchal X, Pertuiset E, Gilson B, Hamidou M, Lanoux P. Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients. Arthritis Rheum. 2003;49:93-100. [PMID: 12579599 DOI: 10.1002/art.10922] [Cited by in Crossref: 176] [Cited by in F6Publishing: 125] [Article Influence: 9.8] [Reference Citation Analysis]
23 Hellemans S, Dens J, Knockaert D. Coronary involvement in the Churg-Strauss syndrome. Heart 1997;77:576-8. [PMID: 9227307 DOI: 10.1136/hrt.77.6.576] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 1.9] [Reference Citation Analysis]
24 Guillevin L, Durand-gasselin B, Cevallos R, Gayraud M, Lhote F, Callard P, Amouroux J, Casassus P, Jarrousse B. Microscopic polyangiitis: Clinical and laboratory findings in eighty-five patients. Arthritis & Rheumatism 1999;42:421-30. [DOI: 10.1002/1529-0131(199904)42:3<421::aid-anr5>3.0.co;2-6] [Cited by in Crossref: 530] [Cited by in F6Publishing: 89] [Article Influence: 24.1] [Reference Citation Analysis]
25 Pagnoux C, Groh M. Optimal therapy and prospects for new medicines in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome). Expert Rev Clin Immunol 2016;12:1059-67. [PMID: 27191665 DOI: 10.1080/1744666X.2016.1191352] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.2] [Reference Citation Analysis]
26 Braun-moscovici Y, Furst DE. Plasmapheresis for rheumatic diseases in the twenty-first century: take it or leave it? Current Opinion in Rheumatology 2003;15:197-204. [DOI: 10.1097/00002281-200305000-00005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
27 Chen Y, Ding Y, Liu Z, Zhang H, Liu Z, Hu W. Long-term outcomes in antineutrophil cytoplasmic autoantibody-positive eosinophilic granulomatosis with polyangiitis patients with renal involvement: a retrospective study of 14 Chinese patients. BMC Nephrol 2016;17:101. [PMID: 27461086 DOI: 10.1186/s12882-016-0319-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Lin YC, Kalot MA, Husainat NM, Byram K, Dua AB, James KE, Springer JM, Turgunbaev M, Villa-Forte A, Abril A, Langford C, Maz M, Chung SA, Mustafa RA. Polyarteritis Nodosa: A Systematic Review of Test Accuracy and Benefits and Harms of Common Treatments. ACR Open Rheumatol 2021;3:91-100. [PMID: 33512781 DOI: 10.1002/acr2.11189] [Reference Citation Analysis]
29 Gumà Uriel M, Valls Roc M, Olivé Marquès A. [Treatment of systemic necrotizing vasculitis and giant cell arteritis]. Med Clin (Barc) 2001;117:191-5. [PMID: 11481086 DOI: 10.1016/s0025-7753(01)72055-6] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
30 Lobbedez T, Comoz F, Renaudineau E, Pujo M, Ryckelynck J, Hurault de Ligny B. Recurrence of ANCA-positive glomerulonephritis immediately after renal transplantation. American Journal of Kidney Diseases 2003;42:e18.1-5. [DOI: 10.1016/s0272-6386(03)00917-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
31 Guillevin L, Pagnoux C. Indication for plasma exchange for systemic necrotizing vasculidities. Transfus Apher Sci 2007;36:179-85. [PMID: 17499762 DOI: 10.1016/j.transci.2007.01.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
32 de Luna G, Chauveau D, Aniort J, Carron P, Gobert P, Karras A, Marchand-adam S, Maurier F, Hatron P, Mania A, le Guenno G, Bally S, Bienvenu B, Cardineau E, Goulenok T, Jourde-chiche N, Samson M, Huart A, Pourrat J, Tiple A, Aumaitre O, Puéchal X, Heshmati F, le Jeunne C, Mouthon L, Guillevin L, Terrier B. Plasma exchanges for the treatment of severe systemic necrotizing vasculitides in clinical daily practice: Data from the French Vasculitis Study Group. Journal of Autoimmunity 2015;65:49-55. [DOI: 10.1016/j.jaut.2015.08.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
33 Schirmer JH, Aries PM, de Groot K, Hellmich B, Holle JU, Kneitz C, Kötter I, Lamprecht P, Müller-Ladner U, Reinhold-Keller E, Specker C, Zänker M, Moosig F. [S1 guidelines Diagnostics and treatment of ANCA-associated vasculitis]. Z Rheumatol 2017;76:77-104. [PMID: 29204681 DOI: 10.1007/s00393-017-0394-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 12] [Article Influence: 17.5] [Reference Citation Analysis]
34 Erhardt A, Sagir A, Guillevin L, Neuen-jacob E, Häussinger D. Successful treatment of hepatitis B virus associated polyarteritis nodosa with a combination of prednisolone, α-interferon and lamivudine. Journal of Hepatology 2000;33:677-83. [DOI: 10.1016/s0168-8278(00)80025-2] [Cited by in Crossref: 15] [Article Influence: 0.7] [Reference Citation Analysis]
35 Lee JJY, Alsaleem A, Chiang GPK, Limenis E, Sontichai W, Yeung RSM, Akikusa J, Laxer RM. Hallmark trials in ANCA-associated vasculitis (AAV) for the pediatric rheumatologist. Pediatr Rheumatol Online J 2019;17:31. [PMID: 31242923 DOI: 10.1186/s12969-019-0343-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
36 Agard C, Mouthon L, Mahr A, Guillevin L. Microscopic polyangiitis and polyarteritis nodosa: How and when do they start? Arthritis & Rheumatism 2003;49:709-15. [DOI: 10.1002/art.11387] [Cited by in Crossref: 76] [Cited by in F6Publishing: 36] [Article Influence: 4.2] [Reference Citation Analysis]
37 de Boysson H, Guillevin L. Polyarteritis Nodosa Neurologic Manifestations. Neurol Clin 2019;37:345-57. [PMID: 30952413 DOI: 10.1016/j.ncl.2019.01.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 6.5] [Reference Citation Analysis]
38 Barros JMD, Antunes T, Barbas CSV. Síndrome de Churg-Strauss. J bras pneumol 2005;31:s27-31. [DOI: 10.1590/s1806-37132005000700008] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
39 Luqmani RA, Exley AR, Kitas GD, Bacon PA. Disease assessment and management of the vasculitides. Baillieres Clin Rheumatol 1997;11:423-46. [PMID: 9220084 DOI: 10.1016/s0950-3579(97)80052-0] [Cited by in Crossref: 75] [Cited by in F6Publishing: 14] [Article Influence: 3.1] [Reference Citation Analysis]
40 Bacon PA, Carruthers D. New therapeutic aspects: haemopoietic stem cell transplantation. Best Practice & Research Clinical Rheumatology 2001;15:299-313. [DOI: 10.1053/berh.2000.0145] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
41 Nardin R, Rutkove S. Neuropathy and Rheumatologic Disease. In: Bromberg M, Smith A, editors. Handbook of Peripheral Neuropathy. CRC Press; 2005. pp. 215-38. [DOI: 10.1201/b14157-17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
42 Jayne D. Update on the European Vasculitis Study Group trials. Curr Opin Rheumatol 2001;13:48-55. [PMID: 11148715 DOI: 10.1097/00002281-200101000-00008] [Cited by in Crossref: 112] [Cited by in F6Publishing: 88] [Article Influence: 5.6] [Reference Citation Analysis]
43 Bourgarit A, Toumelin PL, Pagnoux C, Cohen P, Mahr A, Guern VL, Mouthon L, Guillevin L. Deaths Occurring During the First Year After Treatment Onset for Polyarteritis Nodosa, Microscopic Polyangiitis, and Churg-Strauss Syndrome: A Retrospective Analysis of Causes and Factors Predictive of Mortality Based on 595 Patients. Medicine 2005;84:323-30. [DOI: 10.1097/01.md.0000180793.80212.17] [Cited by in Crossref: 161] [Cited by in F6Publishing: 114] [Article Influence: 10.1] [Reference Citation Analysis]
44 Thiel J, Troilo A, Salzer U, Schleyer T, Halmschlag K, Rizzi M, Frede N, Venhoff A, Voll RE, Venhoff N. Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis. The Journal of Allergy and Clinical Immunology: In Practice 2017;5:1556-63. [DOI: 10.1016/j.jaip.2017.07.027] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 9.5] [Reference Citation Analysis]
45 Cottin V, Cordier J. Churg‐Strauss syndrome. Allergy 2002;54:535-51. [DOI: 10.1034/j.1398-9995.1999.t01-1-00091.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
46 Danieli MG, Cappelli M, Malcangi G, Logullo F, Salvi A, Danieli G. Long term effectiveness of intravenous immunoglobulin in Churg-Strauss syndrome. Ann Rheum Dis 2004;63:1649-54. [PMID: 15547090 DOI: 10.1136/ard.2003.015453] [Cited by in Crossref: 73] [Cited by in F6Publishing: 54] [Article Influence: 4.3] [Reference Citation Analysis]
47 Moosig F, Holle JU, Gross WL. Value of anti-infective chemoprophylaxis in primary systemic vasculitis: what is the evidence? Arthritis Res Ther 2009;11:253. [PMID: 19886977 DOI: 10.1186/ar2826] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
48 Mouthon L, Le Toumelin P, Andre MH, Gayraud M, Casassus P, Guillevin L. Polyarteritis Nodosa and Churg-Strauss Angiitis: Characteristics and Outcome in 38 Patients over 65 Years. Medicine 2002;81:27-40. [DOI: 10.1097/00005792-200201000-00002] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
49 Lhote F, Cohen P, Guillevin L. Polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome. Lupus 1998;7:238-58. [PMID: 9643314 DOI: 10.1191/096120398678920055] [Cited by in Crossref: 135] [Cited by in F6Publishing: 87] [Article Influence: 5.9] [Reference Citation Analysis]
50 Guillevin L, Lhote F. Classification and management of necrotising vasculitides. Drugs 1997;53:805-16. [PMID: 9129867 DOI: 10.2165/00003495-199753050-00006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
51 Gaskin G, Pusey CD. Plasmapheresis in Antineutrophil Cytoplasmic Antibodies‐Associated Systemic Vasculitis. Therapeutic Apheresis 2008;5:176-81. [DOI: 10.1111/j.1526-0968.2001.00300.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
52 Waseem M, Laureta E. An asthmatic adolescent with a rash and eosinophilia. Pediatr Emerg Care 2007;23:727-30. [PMID: 18090108 DOI: 10.1097/PEC.0b013e3181568016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
53 Wi J, Choi HH, Lee CJ, Kim T, Shin S, Ko YG, Jang Y, Park YB, Kwon YJ. Acute Myocardial Infarction due to Polyarteritis Nodosa in a Young Female Patient. Korean Circ J 2010;40:197-200. [PMID: 20421961 DOI: 10.4070/kcj.2010.40.4.197] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
54 Brown KK. Pulmonary vasculitis. Proc Am Thorac Soc 2006;3:48-57. [PMID: 16493151 DOI: 10.1513/pats.200511-120JH] [Cited by in Crossref: 78] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
55 Androudi S, Iaccheri B, Brazitikos P, Papadaki T, Foster CS. Bilateral chronic anterior uveitis & neuro-ophthalmologic manifestations in a patient with Churg-Strauss syndrome: an unusual ocular presentation. Ocul Immunol Inflamm 2004;12:59-63. [PMID: 15209465 DOI: 10.1076/ocii.12.1.59.28071] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
56 Miloslavsky E, Unizony S. The Heart in Vasculitis. Rheumatic Disease Clinics of North America 2014;40:11-26. [DOI: 10.1016/j.rdc.2013.10.006] [Cited by in Crossref: 47] [Cited by in F6Publishing: 32] [Article Influence: 6.7] [Reference Citation Analysis]
57 Rosenbaum R. Neuromuscular complications of connective tissue diseases. Muscle Nerve 2001;24:154-69. [DOI: 10.1002/1097-4598(200102)24:2<154::aid-mus20>3.0.co;2-3] [Cited by in Crossref: 53] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
58 Vena GA, Cassano N. Immunosuppressive therapy in cutaneous vasculitis. Clinics in Dermatology 1999;17:633-40. [DOI: 10.1016/s0738-081x(99)00084-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
59 Jayne DR, Gaskin G, Rasmussen N, Abramowicz D, Ferrario F, Guillevin L, Mirapeix E, Savage CO, Sinico RA, Stegeman CA. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol. 2007;18:2180-2188. [PMID: 17582159 DOI: 10.1681/asn.2007010090] [Cited by in Crossref: 672] [Cited by in F6Publishing: 176] [Article Influence: 48.0] [Reference Citation Analysis]
60 Guillevin L, Lhote F. Treatment of polyarteritis nodosa and microscopic polyangiitis. Arthritis & Rheumatism 1998;41:2100-5. [DOI: 10.1002/1529-0131(199812)41:12<2100::aid-art3>3.0.co;2-j] [Cited by in Crossref: 55] [Cited by in F6Publishing: 1] [Article Influence: 2.4] [Reference Citation Analysis]
61 Pesci A, Manganelli P. Respiratory system involvement in antineutrophil cytoplasmic-associated systemic vasculitides: clinical, pathological, radiological and therapeutic considerations. Drugs R D 2007;8:25-42. [PMID: 17249847 DOI: 10.2165/00126839-200708010-00003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
62 Groh M, Pagnoux C, Baldini C, Bel E, Bottero P, Cottin V, Dalhoff K, Dunogué B, Gross W, Holle J, Humbert M, Jayne D, Jennette JC, Lazor R, Mahr A, Merkel PA, Mouthon L, Sinico RA, Specks U, Vaglio A, Wechsler ME, Cordier JF, Guillevin L. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management. Eur J Intern Med 2015;26:545-53. [PMID: 25971154 DOI: 10.1016/j.ejim.2015.04.022] [Cited by in Crossref: 217] [Cited by in F6Publishing: 169] [Article Influence: 36.2] [Reference Citation Analysis]
63 Burns TM, Schaublin GA, Dyck PJB. Vasculitic Neuropathies. Neurologic Clinics 2007;25:89-113. [DOI: 10.1016/j.ncl.2006.11.002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
64 Le Guenno G, Mahr A, Pagnoux C, Dhote R, Guillevin L; French Vasculitis Study Group. Incidence and predictors of urotoxic adverse events in cyclophosphamide-treated patients with systemic necrotizing vasculitides. Arthritis Rheum 2011;63:1435-45. [PMID: 21337321 DOI: 10.1002/art.30296] [Cited by in Crossref: 57] [Cited by in F6Publishing: 44] [Article Influence: 5.7] [Reference Citation Analysis]
65 Chaigne B, Guillevin L. New therapeutic approaches for ANCA-associated vasculitides. La Presse Médicale 2016;45:e171-8. [DOI: 10.1016/j.lpm.2016.05.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
66 Khasnis A, Langford CA. Update on vasculitis. J Allergy Clin Immunol 2009;123:1226-36. [PMID: 19501230 DOI: 10.1016/j.jaci.2009.04.024] [Cited by in Crossref: 48] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
67 Comarmond C, Pagnoux C, Khellaf M, Cordier JF, Hamidou M, Viallard JF, Maurier F, Jouneau S, Bienvenu B, Puéchal X, Aumaître O, Le Guenno G, Le Quellec A, Cevallos R, Fain O, Godeau B, Seror R, Dunogué B, Mahr A, Guilpain P, Cohen P, Aouba A, Mouthon L, Guillevin L; French Vasculitis Study Group. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum 2013;65:270-81. [PMID: 23044708 DOI: 10.1002/art.37721] [Cited by in Crossref: 440] [Cited by in F6Publishing: 319] [Article Influence: 55.0] [Reference Citation Analysis]
68 Bozkurt B, Colvin M, Cook J, Cooper LT, Deswal A, Fonarow GC, Francis GS, Lenihan D, Lewis EF, McNamara DM, Pahl E, Vasan RS, Ramasubbu K, Rasmusson K, Towbin JA, Yancy C; American Heart Association Committee on Heart Failure and Transplantation of the Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; and Council on Quality of Care and Outcomes Research. Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association. Circulation 2016;134:e579-646. [PMID: 27832612 DOI: 10.1161/CIR.0000000000000455] [Cited by in Crossref: 213] [Cited by in F6Publishing: 116] [Article Influence: 42.6] [Reference Citation Analysis]
69 Baweja S, Wiggins K, Lee D, Blair S, Fraenkel M, Mcmahon LP. Benefits and limitations of plasmapheresis in renal diseases: an evidence-based approach. J Artif Organs 2011;14:9-22. [DOI: 10.1007/s10047-010-0529-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
70 Chung SA, Gorelik M, Langford CA, Maz M, Abril A, Guyatt G, Archer AM, Conn DL, Full KA, Grayson PC, Ibarra MF, Imundo LF, Kim S, Merkel PA, Rhee RL, Seo P, Stone JH, Sule S, Sundel RP, Vitobaldi OI, Warner A, Byram K, Dua AB, Husainat N, James KE, Kalot M, Lin YC, Springer JM, Turgunbaev M, Villa-Forte A, Turner AS, Mustafa RA. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Polyarteritis Nodosa. Arthritis Rheumatol 2021;73:1384-93. [PMID: 34235883 DOI: 10.1002/art.41776] [Reference Citation Analysis]
71 Walsh M, Catapano F, Szpirt W, Thorlund K, Bruchfeld A, Guillevin L, Haubitz M, Merkel PA, Peh CA, Pusey C. Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis. Am J Kidney Dis. 2011;57:566-574. [PMID: 21194817 DOI: 10.1053/j.ajkd.2010.10.049] [Cited by in Crossref: 121] [Cited by in F6Publishing: 81] [Article Influence: 11.0] [Reference Citation Analysis]
72 Régent A, Mouthon L, Guillevin L, Terrier B. Role of therapeutic plasma exchanges in systemic vasculitis. Transfusion and Apheresis Science 2020;59:102992. [DOI: 10.1016/j.transci.2020.102992] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Guillevin L. Treatment of primary systemic necrotizing vasculitides: the role of biotherapies. Clin Exp Nephrol 2013;17:622-7. [PMID: 24018402 DOI: 10.1007/s10157-013-0860-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
74 Terrier B, Darbon R, Durel CA, Hachulla E, Karras A, Maillard H, Papo T, Puechal X, Pugnet G, Quemeneur T, Samson M, Taille C, Guillevin L; Collaborators. French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides). Orphanet J Rare Dis 2020;15:351. [PMID: 33372616 DOI: 10.1186/s13023-020-01621-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
75 Frankel SK, Sullivan EJ, Brown KK. Vasculitis: Wegener granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis, polyarteritis nodosa, and Takayasu arteritis. Critical Care Clinics 2002;18:855-79. [DOI: 10.1016/s0749-0704(02)00031-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
76 Casal Moura M, Irazabal MV, Eirin A, Zand L, Sethi S, Borah BJ, Winters JL, Moriarty JP, Cartin-Ceba R, Berti A, Baqir M, Thompson GE, Makol A, Warrington KJ, Thao V, Specks U, Fervenza FC. Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Severe Kidney Disease. J Am Soc Nephrol 2020;31:2688-704. [PMID: 32826324 DOI: 10.1681/ASN.2019111197] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
77 Guillevin L. Treatment of classic polyarteritis nodosa in 1999. Nephrol Dial Transplant. 1999;14:2077-2079. [PMID: 10489209 DOI: 10.1093/ndt/14.9.2077] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
78 Collins MP, Kissel JT. Neuropathies with Systemic Vasculitis. Peripheral Neuropathy. Elsevier; 2005. pp. 2335-404. [DOI: 10.1016/b978-0-7216-9491-7.50108-3] [Cited by in Crossref: 12] [Article Influence: 0.8] [Reference Citation Analysis]
79 Frankel SK, Cosgrove GP, Fischer A, Meehan RT, Brown KK. Update in the Diagnosis and Management of Pulmonary Vasculitis. Chest 2006;129:452-65. [DOI: 10.1378/chest.129.2.452] [Cited by in Crossref: 100] [Cited by in F6Publishing: 51] [Article Influence: 6.7] [Reference Citation Analysis]
80 Moussi-frances J, Sallée M, Jourde-chiche N. Apheresis to treat systemic vasculitis. Joint Bone Spine 2018;85:177-83. [DOI: 10.1016/j.jbspin.2017.06.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
81 Gaskin G, Pusey CD. Plasmapheresis in Antineutrophil Cytoplasmic Antibodies-Associated Systemic Vasculitis. Therapher Dial 2001;5:176-81. [DOI: 10.1046/j.1526-0968.2001.00300.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
82 Tsujimoto K, Yagita M, Taniguchi M, Fujita M. Successful Use of Plasma Exchange in the Treatment of Corticosteroid-Refractory Eosinophilic Granulomatosis with Polyangiitis Associated with Gastrointestinal Manifestations. Case Reports Immunol 2016;2016:8341751. [PMID: 26989530 DOI: 10.1155/2016/8341751] [Reference Citation Analysis]
83 Holle JU, Moosig F, Gross WL. Diagnostic and therapeutic management of Churg-Strauss syndrome. Expert Rev Clin Immunol 2009;5:813-23. [PMID: 20477699 DOI: 10.1586/eci.09.41] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
84 Guillevin L. Treatment of severe and/or refractory ANCA-associated vasculitis. Curr Rheumatol Rep 2014;16:430. [PMID: 24925586 DOI: 10.1007/s11926-014-0430-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
85 Jayne D. How to induce remission in primary systemic vasculitis. Best Practice & Research Clinical Rheumatology 2005;19:293-305. [DOI: 10.1016/j.berh.2004.11.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
86 Holle J, Gross W. ANCA-associated vasculitides: Pathogenetic aspects and current evidence-based therapy. Journal of Autoimmunity 2009;32:163-71. [DOI: 10.1016/j.jaut.2009.02.019] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
87 Wang CR, Tsai HW. Human hepatitis viruses-associated cutaneous and systemic vasculitis. World J Gastroenterol 2021; 27(1): 19-36 [PMID: 33505148 DOI: 10.3748/wjg.v27.i1.19] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
88 Semple D, Keogh J, Forni L, Venn R. Clinical review: Vasculitis on the intensive care unit -- part 2: treatment and prognosis. Crit Care 2005;9:193-7. [PMID: 15774077 DOI: 10.1186/cc2937] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
89 Eleftheriou D, Gale H, Pilkington C, Fenton M, Sebire NJ, Brogan PA. Eosinophilic granulomatosis with polyangiitis in childhood: retrospective experience from a tertiary referral centre in the UK. Rheumatology (Oxford) 2016;55:1263-72. [PMID: 27026726 DOI: 10.1093/rheumatology/kew029] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
90 Dillon MJ. Vasculitis treatment – new therapeutic approaches. Eur J Pediatr 2006;165:351-7. [DOI: 10.1007/s00431-005-0070-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
91 Erden A, Batu ED, Sönmez HE, Sarı A, Armagan B, Arıcı ZS, Bilgin E, Kalyoncu U, Karadağ Ö, Bilginer Y, Ertenli AI, Özen S. Comparing polyarteritis nodosa in children and adults: a single center study. Int J Rheum Dis 2017;20:1016-22. [PMID: 28626961 DOI: 10.1111/1756-185X.13120] [Cited by in Crossref: 17] [Cited by in F6Publishing: 3] [Article Influence: 4.3] [Reference Citation Analysis]
92 Carruthers DM, Bacon PA. Autologous stem cell therapy for systemic vasculitis. In: Kallenberg CGM, Tervaert JWC, editors. Disease-modifying Therapy in Vasculitides. Basel: Birkhäuser; 2001. pp. 159-80. [DOI: 10.1007/978-3-0348-8235-4_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
93 Pagnoux C, Seror R, Henegar C, Mahr A, Cohen P, Le Guern V, Bienvenu B, Mouthon L, Guillevin L;  French Vasculitis Study Group. Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum. 2010;62:616-626. [PMID: 20112401 DOI: 10.1002/art.27240] [Cited by in Crossref: 335] [Cited by in F6Publishing: 201] [Article Influence: 30.5] [Reference Citation Analysis]
94 Guillevin L. Clinical trials on systemic necrotizing vasculitides. La Presse Médicale 2010;39:653-9. [DOI: 10.1016/j.lpm.2009.12.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
95 Chalk CH. Acquired peripheral neuropathy. Neurol Clin 1997;15:501-28. [PMID: 9227950 DOI: 10.1016/s0733-8619(05)70331-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
96 Guillevin L, Terrier B. Maintenance of Remission in antineutrophil cytoplasm antibody-associated vasculitides. Int J Rheum Dis 2019;22 Suppl 1:100-4. [PMID: 29673090 DOI: 10.1111/1756-185X.13303] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
97 Mahr A, Chaigne-delalande S, De Menthon M. Therapeutic plasma exchange in systemic vasculitis: an update on indications and results. Current Opinion in Rheumatology 2012;24:261-6. [DOI: 10.1097/bor.0b013e3283526509] [Cited by in Crossref: 7] [Article Influence: 0.8] [Reference Citation Analysis]
98 Jayne D. Clinical management and treatment of vasculitis. Springer Semin Immunopathol 2001;23:267-86. [DOI: 10.1007/s002810100080] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
99 Guillevin L, Lhote F, Gherardi R. Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: clinical aspects, neurologic manifestations, and treatment. Neurol Clin 1997;15:865-86. [PMID: 9367969 DOI: 10.1016/s0733-8619(05)70352-2] [Cited by in Crossref: 39] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
100 Cornec D, Cornec-Le Gall E, Specks U. Clinical trials in antineutrophil cytoplasmic antibody-associated vasculitis: what we have learnt so far, and what we still have to learn. Nephrol Dial Transplant 2017;32:i37-47. [PMID: 28087591 DOI: 10.1093/ndt/gfw384] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
101 Casian A, Jayne D. Plasma exchange in the treatment of Wegener's granulomatosis, microscopic polyangiitis, Churg–Strauss syndrome and renal limited vasculitis. Current Opinion in Rheumatology 2011;23:12-7. [DOI: 10.1097/bor.0b013e32834120c1] [Cited by in Crossref: 47] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
102 Schirmer JH, Holl-Ulrich K, Moosig F. [Polyarteritis nodosa: differential diagnostics and therapy]. Z Rheumatol 2014;73:917-26; quiz 926-7. [PMID: 25391370 DOI: 10.1007/s00393-014-1483-z] [Cited by in Crossref: 5] [Article Influence: 0.8] [Reference Citation Analysis]
103 Guillevin L. Therapeutic strategies in systemic necrotizing vasculitides. Acta Clin Belg 2001;56:103-12. [PMID: 11383313 DOI: 10.1179/acb.2001.018] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
104 Correia SI, Eira I, Santa Cruz A, Ângela C. Pulmonary-renal syndrome: diagnostic challenge. BMJ Case Rep 2019;12:e227720. [PMID: 31028048 DOI: 10.1136/bcr-2018-227720] [Reference Citation Analysis]
105 Ribi C, Cohen P, Pagnoux C, Mahr A, Arène JP, Puéchal X, Carli P, Kyndt X, Le Hello C, Letellier P. Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: A prospective randomized study of one hundred twenty-four patients. Arthritis Rheum. 2010;62:1186-1197. [PMID: 20131268 DOI: 10.1002/art.27340] [Cited by in Crossref: 140] [Cited by in F6Publishing: 90] [Article Influence: 12.7] [Reference Citation Analysis]
106 Eleftheriou D, Dillon MJ, Tullus K, Marks SD, Pilkington CA, Roebuck DJ, Klein NJ, Brogan PA. Systemic Polyarteritis Nodosa in the Young: A Single‐Center Experience Over Thirty‐Two Years. Arthritis & Rheumatism 2013;65:2476-85. [DOI: 10.1002/art.38024] [Cited by in Crossref: 73] [Cited by in F6Publishing: 44] [Article Influence: 9.1] [Reference Citation Analysis]
107 Schaublin GA, Michet CJ, Dyck PJB, Burns TM. An update on the classification and treatment of vasculitic neuropathy. The Lancet Neurology 2005;4:853-65. [DOI: 10.1016/s1474-4422(05)70249-0] [Cited by in Crossref: 58] [Cited by in F6Publishing: 10] [Article Influence: 3.6] [Reference Citation Analysis]
108 Courtney R. H, Glenn G. R. Polyarteritis Nodosa and Cutaneous Polyarteritis Nodosa. SKINmed: Dermatology for the Clinician 2007;2:277-86. [DOI: 10.1111/j.1540-9740.2003.02214.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
109 Hellmich B, Flossmann O, Gross WL, Bacon P, Cohen-Tervaert JW, Guillevin L, Jayne D, Mahr A, Merkel PA, Raspe H, Scott DG, Witter J, Yazici H, Luqmani RA. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis 2007;66:605-17. [PMID: 17170053 DOI: 10.1136/ard.2006.062711] [Cited by in Crossref: 388] [Cited by in F6Publishing: 325] [Article Influence: 25.9] [Reference Citation Analysis]
110 Gatenby PA. Vasculitis - diagnosis and treatment. Australian and New Zealand Journal of Medicine 1999;29:662-77. [DOI: 10.1111/j.1445-5994.1999.tb01614.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
111 De Golovine S, Parikh S, Lu L. A case of polyarteritis nodosa presenting initially as peripheral vascular disease. J Gen Intern Med 2008;23:1528-31. [PMID: 18560943 DOI: 10.1007/s11606-008-0683-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
112 Frankel SK, Cosgrove GP, Brown KK. Small vessel vasculitis of the lung. Chron Respir Dis 2005;2:75-84. [DOI: 10.1191/1479972305cd070rs] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]